TargetGene Biotechnologies Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

TargetGene Biotechnologies General Information

Description

Provider of DNA editing services in living organisms. The company specializes in providing gene-specific DNA genome editing services in living organisms.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Oppenheimer 10
  • Floor 3
  • Rehovot
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TargetGene Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TargetGene Biotechnologies‘s full profile, request access.

Request a free trial

TargetGene Biotechnologies Patents

TargetGene Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020373362-A1 Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation Pending 28-Oct-2019 0000000000
CA-3159576-A1 Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation Pending 28-Oct-2019 0000000000
EP-4051792-A1 Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation Pending 28-Oct-2019 0000000000
EP-2790708-A1 Compositions and methods for modifying a predetermined target nucleic acid sequence Pending 16-Dec-2011 000000000
EP-2790708-A4 Compositions and methods for modifying a predetermined target nucleic acid sequence Pending 16-Dec-2011 A61K38/00
To view TargetGene Biotechnologies’s complete patent history, request access »

TargetGene Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Yoel Shiboleth Ph.D Co-Founder & Chief Executive Officer
Dan Weinthal Ph.D Co-Founder & Chief Operating Officer
To view TargetGene Biotechnologies’s complete executive team members history, request access »

TargetGene Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TargetGene Biotechnologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TargetGene Biotechnologies‘s full profile, request access.

Request a free trial